Literature DB >> 22055680

Preventing HIV in U.S. women and girls: a call for social action.

Cynthia A Gómez1.   

Abstract

Successes in HIV prevention efforts in the U.S. have resulted in drastic reductions in the number of new infections in the U.S. among white gay men and injection drug users, a stabilization in overall annual rates of new HIV infections, and near eradication of mother-to child transmission of HIV. Despite this remarkable progress, the proportion of AIDS cases in women has slowly, quietly, and steadily increased from 7% in 1985 to 25% in 2008. The fact the prevention efforts have not reduced HIV spread among women suggests that targeting the individual behaviors of women to prevent HIV acquisition is not a sufficiently effective public health strategy. Interventions that more broadly address the needs of women and their families, and address the contextual factors in which HIV risk occurs are more likely to lead to measurable and sustainable progress. Over the past 30 years, we have seen the U.S. HIV epidemic in women become similar to patterns of HIV risk among women in the developing world. In 2009, 85% of women who acquired HIV became infected through sex with a man and the majority (83%) of them were non-white women. Efforts to understand these immense disparities and create gender-responsive strategies must be a priority within our National HIV/AIDS Strategy. Copyright Â
© 2011 Jacobs Institute of Women's Health. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22055680     DOI: 10.1016/j.whi.2011.07.012

Source DB:  PubMed          Journal:  Womens Health Issues        ISSN: 1049-3867


  6 in total

1.  Women's experiences with HIV-related stigma from health care providers in Lima, Peru: "I would rather die than go back for care".

Authors:  Dellanira Valencia-Garcia; Deepa Rao; Lara Strick; Jane M Simoni
Journal:  Health Care Women Int       Date:  2016-08-02

2.  Reducing risky relationships: a multisite randomized trial of a prison-based intervention for reducing HIV sexual risk behaviors among women with a history of drug use.

Authors:  Hannah K Knudsen; Michele Staton-Tindall; Carrie B Oser; Jennifer R Havens; Carl G Leukefeld
Journal:  AIDS Care       Date:  2014-01-13

3.  Evaluation of the lymphocyte trafficking drug FTY720 in vaginal tissues.

Authors:  Ai Tsuiki; Wei Luo; Tara Henning; Sundaram Vishwanathan; Chuong Dinh; Debra Adams; Elizabeth Sweeney; James Mitchell; Shannon Bachman; Prachi Sharma; Nathaniel Powell; Michael Hendry; Janet McNicholl; Ellen Kersh
Journal:  J Med Primatol       Date:  2013-01-12       Impact factor: 0.667

4.  Exploring the influence of social determinants on HIV risk behaviors and the potential application of structural interventions to prevent HIV in women.

Authors:  Arlene E Edwards; Charles B Collins
Journal:  J Health Dispar Res Pract       Date:  2014

5.  Exit interviews from adolescent girls who participated in a sexual risk-reduction intervention: implications for community-based health education promotion for adolescents.

Authors:  Dianne Morrison-Beedy; Denise Passmore; Michael P Carey
Journal:  J Midwifery Womens Health       Date:  2013 May-Jun       Impact factor: 2.388

6.  "Yes, I'm interested in taking PrEP!": PrEP interest among women respondents to the European community-based survey "Flash! PrEP in Europe".

Authors:  Rosemary M Delabre; Adeline Bernier; Flor Sánchez; Antoine Vilotitch; Sophocles Chanos; Maria Luisa Cosmaro; Harriet Langanke; Coline Mey; Cary James; Sascha B Duken; Vincent Schlegel; Richard Stranz; Kai J Jonas; Bruno Spire; Daniela Rojas Castro
Journal:  PLoS One       Date:  2021-02-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.